Effect of late prophylaxis in hemophilia on joint status: a randomized trial
Rattachement africain : us, se, de, bg, ro, ar. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Essentials High-quality data are lacking on use of prophylaxis in adults with hemophilia and arthropathy. SPINART was a 3-year randomized clinical trial of late/tertiary prophylaxis vs on-demand therapy. Prophylaxis improved function, quality of life, activity and pain but not joint structure by MRI. Prophylaxis improves function but must start before joint bleeding onset to prevent arthropathy. SUMMARY: Background Limited data exist on the impact of prophylaxis on adults with severe hemophilia A and pre-existing joint disease. Objectives To describe 3-year bleeding, joint health and structure, health-related quality-of-life (HRQoL) and other outcomes from the open-label, randomized, multinational SPINART study. Patients/Methods Males aged 12-50 years with severe hemophilia A, ≥ 150 factor VIII exposure days, no inhibitors and no prophylaxis for > 12 consecutive months in the past 5 years were randomized to sucrose-formulated recombinant FVIII prophylaxis or on-demand therapy (OD). Data collected included total and joint bleeding events (BEs), joint structure (magnetic resonance imaging [MRI]), joint health (Colorado Adult Joint Assessment Scale [CAJAS]), HRQoL, pain, healthcare resource utilization (HRU), activity, and treatment satisfaction. Results Following 3 years of prophylaxis, adults maintained excellent adherence, with a 94% reduction in BEs despite severe pre-existing arthropathy; 35.7% and 76.2% of prophylaxis participants were bleed-free or had fewer than two BEs per year, respectively. As compared with OD, prophylaxis was associated with improved CAJAS scores (least squares [LS] mean, - 0.31 [n = 42] versus + 0.63 [n = 42]) and HAEMO-QoL-A scores (LS mean, + 3.98 [n = 41] versus - 6.00 [n = 42]), less chronic pain (50% decrease), and approximately two-fold less HRU; activity, Euro QoL-5D-3L (EQ-5D-3L) scores and satisfaction scores also favored prophylaxis. However, MRI score changes were not different for prophylaxis versus OD (LS mean, + 0.79 [n = 41] versus + 0.96 [n = 38]). Conclusions Over a period of 3 years, prophylaxis versus OD in adults with severe hemophilia A and arthropathy led to decreased bleeding, pain, and HRU, better joint health, activity, satisfaction, and HRQoL, but no reduction in structural arthropathy progression, suggesting that pre-existing joint arthropathy may be irreversible.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effect of late prophylaxis in hemophilia on joint status: a randomized trial
- Date Crossref
- 01/11/2017
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Colorado Anschutz pays non établi dans la noticeUniversité ou école supérieure
-
Lund University pays non établi dans la noticeUniversité ou école supérieure
-
Skåne University Hospital pays non établi dans la noticeÉtablissement de santé
-
Martin-Luther-Krankenhaus pays non établi dans la noticeÉtablissement de santé
-
Charité - Universitätsmedizin Berlin pays non établi dans la noticeÉtablissement de santé
-
Emory University pays non établi dans la noticeUniversité ou école supérieure
-
University of Minnesota pays non établi dans la noticeUniversité ou école supérieure
-
Medical University Plovdiv pays non établi dans la noticeUniversité ou école supérieure
-
University Multipurpose Hospital for Active Treatment "Sveti Georgi" pays non établi dans la noticeÉtablissement de santé
-
University Hospital St. Marina pays non établi dans la noticeÉtablissement de santé
-
Institutul Clinic Fundeni pays non établi dans la noticeÉtablissement de santé
-
Hospital Ramos Mejía pays non établi dans la noticeÉtablissement de santé
University of Colorado Anschutz, Lund University et Skåne University Hospital, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.